Natixis’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $339K | Buy |
+2,641
| New | +$339K | ﹤0.01% | 729 |
|
|
2025
Q1 | – | Sell |
-465
| Closed | -$40.6K | – | 967 |
|
|
2024
Q4 | $40.6K | Sell |
465
-89
| -16% | -$7.76K | ﹤0.01% | 887 |
|
|
2024
Q3 | $51.2K | Sell |
554
-29
| -5% | -$2.68K | ﹤0.01% | 770 |
|
|
2024
Q2 | $62.8K | Sell |
583
-185
| -24% | -$19.9K | ﹤0.01% | 760 |
|
|
2024
Q1 | $72.9K | Buy |
+768
| New | +$72.9K | ﹤0.01% | 782 |
|
|
2022
Q1 | – | Sell |
-2,286
| Closed | -$245K | – | 1170 |
|
|
2021
Q4 | $245K | Sell |
2,286
-149
| -6% | -$16K | ﹤0.01% | 1147 |
|
|
2021
Q3 | $250K | Sell |
2,435
-19
| -0.8% | -$1.95K | ﹤0.01% | 1121 |
|
|
2021
Q2 | $216K | Buy |
+2,454
| New | +$216K | ﹤0.01% | 812 |
|
|
2020
Q4 | – | Sell |
-329,844
| Closed | -$30.6M | – | 1041 |
|
|
2020
Q3 | $30.6M | Buy |
+329,844
| New | +$30.6M | 0.23% | 111 |
|